Literature DB >> 21134755

Identification of novel ASK1 inhibitors using virtual screening.

Masako Okamoto1, Nae Saito, Hirotatsu Kojima, Takayoshi Okabe, Kohsuke Takeda, Hidenori Ichijo, Toshio Furuya, Tetsuo Nagano.   

Abstract

Apoptosis signal-regulating kinase 1 (ASK1, also called MAP3K5) is a mitogen-activated protein kinase kinase kinase (MAP3K) that plays important roles in stress-induced cell death and inflammation, and is expected as a new therapeutic target for cancer, cardiovascular diseases, and neurodegenerative diseases. We identified novel ASK1 inhibitors by virtual screening from the public chemical library collected by Chemical Biology Research Initiative (CBRI) at the University of Tokyo. Copyright Â
© 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21134755     DOI: 10.1016/j.bmc.2010.11.004

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  5 in total

1.  Discovery of 2-arylquinazoline derivatives as a new class of ASK1 inhibitors.

Authors:  Andrii Monastyrskyi; Simon Bayle; Victor Quereda; Wayne Grant; Michael Cameron; Derek Duckett; William Roush
Journal:  Bioorg Med Chem Lett       Date:  2017-12-13       Impact factor: 2.823

2.  ASK1 contributes to fibrosis and dysfunction in models of kidney disease.

Authors:  John T Liles; Britton K Corkey; Gregory T Notte; Grant R Budas; Eric B Lansdon; Ford Hinojosa-Kirschenbaum; Shawn S Badal; Michael Lee; Brian E Schultz; Sarah Wise; Swetha Pendem; Michael Graupe; Laurie Castonguay; Keith A Koch; Melanie H Wong; Giuseppe A Papalia; Dorothy M French; Theodore Sullivan; Erik G Huntzicker; Frank Y Ma; David J Nikolic-Paterson; Tareq Altuhaifi; Haichun Yang; Agnes B Fogo; David G Breckenridge
Journal:  J Clin Invest       Date:  2018-07-19       Impact factor: 14.808

3.  Crystal structures of ASK1-inhibtor complexes provide a platform for structure-based drug design.

Authors:  Onkar Singh; Anthony Shillings; Peter Craggs; Ian Wall; Paul Rowland; Tadeusz Skarzynski; Clare I Hobbs; Phil Hardwick; Rob Tanner; Michelle Blunt; David R Witty; Kathrine J Smith
Journal:  Protein Sci       Date:  2013-07-03       Impact factor: 6.725

4.  Development of an HTS-compatible assay for the discovery of ASK1 signalosome inhibitors using alphascreen technology.

Authors:  Emmanuel Sturchler; Weimin Chen; Timothy Spicer; Peter Hodder; Patricia McDonald; Derek Duckett
Journal:  Assay Drug Dev Technol       Date:  2014-05       Impact factor: 1.738

Review 5.  Therapeutic targets in the ASK1-dependent stress signaling pathways.

Authors:  Ryoichi Hayakawa; Teruyuki Hayakawa; Kohsuke Takeda; Hidenori Ichijo
Journal:  Proc Jpn Acad Ser B Phys Biol Sci       Date:  2012       Impact factor: 3.493

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.